$LAZ
Lazard, Inc.

2021 Q1 Form 10-Q Financial Statement

#000156459021022899 Filed on May 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $660.1M $558.2M
YoY Change 18.27% -15.65%
Cost Of Revenue $49.10M $46.50M
YoY Change 5.59% -0.85%
Gross Profit $630.8M $511.6M
YoY Change 23.3% -16.77%
Gross Profit Margin 95.56% 91.66%
Selling, General & Admin $491.6M $418.0M
YoY Change 17.61% -11.96%
% of Gross Profit 77.93% 81.7%
Research & Development $33.67M
YoY Change
% of Gross Profit 5.34%
Depreciation & Amortization $9.400M $8.986M
YoY Change 4.61% 9.77%
% of Gross Profit 1.49% 1.76%
Operating Expenses $33.67M $427.6M
YoY Change -92.13% -13.11%
Operating Profit $134.3M $84.10M
YoY Change 59.68% -29.72%
Interest Expense $20.14M
YoY Change 11.88%
% of Operating Profit 23.95%
Other Income/Expense, Net
YoY Change
Pretax Income $134.3M $84.10M
YoY Change 59.69% -29.74%
Income Tax $43.50M $25.77M
% Of Pretax Income 32.39% 30.64%
Net Earnings $87.30M $64.02M
YoY Change 36.36% -34.03%
Net Earnings / Revenue 13.23% 11.47%
Basic Earnings Per Share $0.80 $0.59
Diluted Earnings Per Share $0.75 $0.56
COMMON SHARES
Basic Shares Outstanding 107.3M 106.3M
Diluted Shares Outstanding 115.8M 114.1M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.604B $1.916B
YoY Change 35.93% -12.48%
Cash & Equivalents $974.7M $793.5M
Short-Term Investments
Other Short-Term Assets $41.40M
YoY Change 5.34%
Inventory
Prepaid Expenses
Receivables $556.2M $478.9M
Other Receivables $183.4M $109.8M
Total Short-Term Assets $3.344B $2.504B
YoY Change 33.51% -13.17%
LONG-TERM ASSETS
Property, Plant & Equipment $250.5M $220.3M
YoY Change 13.72% 5.11%
Goodwill $381.8M $355.7M
YoY Change 7.32% -4.47%
Intangibles
YoY Change
Long-Term Investments $782.4M $505.8M
YoY Change 54.69% -17.86%
Other Assets $506.8M $569.5M
YoY Change -11.01% -3.75%
Total Long-Term Assets $2.866B $2.591B
YoY Change 10.62% -0.94%
TOTAL ASSETS
Total Short-Term Assets $3.344B $2.504B
Total Long-Term Assets $2.866B $2.591B
Total Assets $6.210B $5.095B
YoY Change 21.87% -7.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.240B $1.145B
YoY Change 8.27% -12.99%
Accrued Expenses $1.068B $962.8M
YoY Change 10.92% 9.67%
Deferred Revenue
YoY Change
Short-Term Debt $3.200M $12.10M
YoY Change -73.55% 572.22%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $2.311B $2.120B
YoY Change 9.01% -3.45%
LONG-TERM LIABILITIES
Long-Term Debt $2.258B $1.680B
YoY Change 34.41% -4.5%
Other Long-Term Liabilities $771.4M $734.4M
YoY Change 5.04% -4.9%
Total Long-Term Liabilities $3.030B $2.415B
YoY Change 25.48% -4.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.311B $2.120B
Total Long-Term Liabilities $3.030B $2.415B
Total Liabilities $5.445B $4.609B
YoY Change 18.14% -3.95%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $765.0M $486.4M
YoY Change
Total Liabilities & Shareholders Equity $6.210B $5.095B
YoY Change 21.87% -7.35%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $87.30M $64.02M
YoY Change 36.36% -34.03%
Depreciation, Depletion And Amortization $9.400M $8.986M
YoY Change 4.61% 9.77%
Cash From Operating Activities -$123.3M -$156.0M
YoY Change -20.95% -3.27%
INVESTING ACTIVITIES
Capital Expenditures -$7.500M $12.01M
YoY Change -162.44% 104.58%
Acquisitions
YoY Change
Other Investing Activities $600.0K $100.0K
YoY Change 500.0% 0.0%
Cash From Investing Activities -$6.900M -$11.94M
YoY Change -42.22% 105.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $122.7M $95.23M
YoY Change 28.8% -50.43%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 244.5M -310.2M
YoY Change -178.83% -431.49%
NET CHANGE
Cash From Operating Activities -123.3M -156.0M
Cash From Investing Activities -6.900M -11.94M
Cash From Financing Activities 244.5M -310.2M
Net Change In Cash 35.10M -539.9M
YoY Change -106.5% 423.1%
FREE CASH FLOW
Cash From Operating Activities -$123.3M -$156.0M
Capital Expenditures -$7.500M $12.01M
Free Cash Flow -$115.8M -$168.0M
YoY Change -31.07% 0.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-19743000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-50746000
CY2021Q1 laz Payments Relating To Customer Deposits
PaymentsRelatingToCustomerDeposits
58739000
CY2020Q1 laz Payments Relating To Customer Deposits
PaymentsRelatingToCustomerDeposits
70652000
CY2021Q1 laz Settlement Of Share Based Incentive Compensation
SettlementOfShareBasedIncentiveCompensation
64804000
CY2020Q1 laz Settlement Of Share Based Incentive Compensation
SettlementOfShareBasedIncentiveCompensation
66728000
CY2021Q1 laz Payments For Other Financing Activities
PaymentsForOtherFinancingActivities
14302000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
244519000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-79205000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
35104000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2568827000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
974696000
CY2021Q1 laz Deposits With Banks And Short Term Investments
DepositsWithBanksAndShortTermInvestments
1014145000
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
615090000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
681574000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
58331000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-39763000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
72161000
CY2020Q1 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
1863000
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.47
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
48759000
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
95227000
CY2020Q1 laz Tax Expense Benefit From Stock Issued In Connection With Sharebased Incentive Compensation
TaxExpenseBenefitFromStockIssuedInConnectionWithSharebasedIncentiveCompensation
-347000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-66380000
CY2020Q1 laz Stock Issued Issuable During Period Value Business Acquisitions Mergers And Amortization
StockIssuedIssuableDuringPeriodValueBusinessAcquisitionsMergersAndAmortization
52000
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1386000
CY2020Q1 laz Consolidated Variable Interest Entities
ConsolidatedVariableInterestEntities
8452000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
559617000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
999433000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
90826000
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.47
CY2021Q1 laz Tax Expense Benefit From Stock Issued In Connection With Sharebased Incentive Compensation
TaxExpenseBenefitFromStockIssuedInConnectionWithSharebasedIncentiveCompensation
-1089000
CY2021Q1 laz Consolidated Variable Interest Entities
ConsolidatedVariableInterestEntities
7775000
CY2021Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-40925000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
866699000
CY2019Q1 laz Governing Operating Agreement Date
GoverningOperatingAgreementDate
2019-02-04
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2020Q4 laz Financing Fee Receivable
FinancingFeeReceivable
90521000
CY2021Q1 laz Aggregate Carrying Amount Other Receivables
AggregateCarryingAmountOtherReceivables
537835000
CY2020Q4 laz Aggregate Carrying Amount Other Receivables
AggregateCarryingAmountOtherReceivables
552655000
CY2021Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
782351000
CY2020Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
658532000
CY2021Q1 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
3221000
CY2020Q4 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
1176000
CY2020Q1 laz New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification1
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification1
7575000
CY2021Q1 laz Allowance For Doubtful Accounts Receivable Charge Offs Foreign Currency Translation And Other Adjustments
AllowanceForDoubtfulAccountsReceivableChargeOffsForeignCurrencyTranslationAndOtherAdjustments
2022000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
31287000
CY2021Q1 laz Financing Fee Receivable
FinancingFeeReceivable
90826000
CY2021Q1 us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
1054000
CY2020Q1 us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
-44432000
CY2021Q1 us-gaap Derivative Assets
DerivativeAssets
1254000
CY2021Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
783605000
CY2021Q1 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
3221000
CY2021Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
395424000
CY2021Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
398645000
CY2020Q4 us-gaap Derivative Assets
DerivativeAssets
536000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
659068000
CY2020Q4 us-gaap Financial Instruments Sold Not Yet Purchased At Fair Value
FinancialInstrumentsSoldNotYetPurchasedAtFairValue
1176000
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
314485000
CY2020Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
315661000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
3157000
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
3113000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
11500000
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
0
CY2021Q1 laz Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Foreign Currency Translation Adjustments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityForeignCurrencyTranslationAdjustments
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
11500000
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
2971000
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
-123000
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
0
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
0
CY2020Q1 laz Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Foreign Currency Translation Adjustments
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignCurrencyTranslationAdjustments
-76000
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
2772000
CY2021Q1 laz Fair Value Transfers Into Or Out Of Level3
FairValueTransfersIntoOrOutOfLevel3
0
CY2020Q1 laz Fair Value Transfers Into Or Out Of Level3
FairValueTransfersIntoOrOutOfLevel3
0
CY2021Q1 us-gaap Alternative Investment
AlternativeInvestment
60526000
CY2021Q1 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
5865000
CY2020Q4 us-gaap Alternative Investment
AlternativeInvestment
52985000
CY2020Q4 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
5865000
CY2021Q1 us-gaap Derivative Assets
DerivativeAssets
1254000
CY2020Q4 us-gaap Derivative Assets
DerivativeAssets
536000
CY2021Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
395424000
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
314485000
CY2021Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4948000
CY2020Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
40254000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
649506000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
660058000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
398968000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
402471000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
250538000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
257587000
CY2021Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
195000
CY2021Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
381947000
CY2020Q4 us-gaap Goodwill
Goodwill
383861000
CY2021Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2109000
CY2021Q1 us-gaap Goodwill
Goodwill
381752000
CY2021Q1 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
70393000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
70198000
CY2020Q4 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
70365000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
70155000
CY2020Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
210000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
446000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
45000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
60000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
60000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
30000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
195000
CY2021Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
2899541
CY2021Q1 laz Average Price Per Common Share
AveragePricePerCommonShare
42.30
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3526000
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5691000
CY2020Q1 laz Weighted Average Number Of Shares Outstanding Basic Before Adjustments
WeightedAverageNumberOfSharesOutstandingBasicBeforeAdjustments
104462177
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
72161000
CY2021Q1 laz Amortization Of Awarded Grants Net Of Forfeitures
AmortizationOfAwardedGrantsNetOfForfeitures
30023000
CY2020Q1 laz Amortization Of Awarded Grants Net Of Forfeitures
AmortizationOfAwardedGrantsNetOfForfeitures
26248000
CY2021Q1 laz Compensation Expense Related To Change In Fair Value Of Underlying Investments
CompensationExpenseRelatedToChangeInFairValueOfUnderlyingInvestments
7487000
CY2020Q1 laz Compensation Expense Related To Change In Fair Value Of Underlying Investments
CompensationExpenseRelatedToChangeInFairValueOfUnderlyingInvestments
-19637000
CY2021Q1 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
37510000
CY2020Q1 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
6611000
CY2021Q1 laz Weighted Average Number Of Basic Shares Outstanding Adjustment
WeightedAverageNumberOfBasicSharesOutstandingAdjustment
1746287
CY2020Q1 laz Weighted Average Number Of Basic Shares Outstanding Adjustment
WeightedAverageNumberOfBasicSharesOutstandingAdjustment
1841785
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107291560
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106303962
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2020Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
1013000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
63009000
CY2021Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
-1292000
CY2020Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
-1013000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
87300000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
64022000
CY2021Q1 laz Weighted Average Number Of Shares Outstanding Basic Before Adjustments
WeightedAverageNumberOfSharesOutstandingBasicBeforeAdjustments
105545273
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8530734
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7816217
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115822294
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114120179
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2021Q1 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
660107000
CY2020Q1 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
538014000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
525817000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
453917000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
134290000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
84097000
CY2021Q1 us-gaap Assets
Assets
6209559000
CY2020Q4 us-gaap Assets
Assets
5971861000

Files In Submission

Name View Source Status
R38.htm Edgar Link pending
0001564590-21-022899-index-headers.html Edgar Link pending
0001564590-21-022899-index.html Edgar Link pending
0001564590-21-022899.txt Edgar Link pending
0001564590-21-022899-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
laz-10q_20210331.htm Edgar Link pending
laz-10q_20210331_htm.xml Edgar Link completed
laz-20210331.xsd Edgar Link pending
laz-20210331_cal.xml Edgar Link unprocessable
laz-20210331_def.xml Edgar Link unprocessable
laz-20210331_lab.xml Edgar Link unprocessable
laz-20210331_pre.xml Edgar Link unprocessable
laz-ex1013_526.htm Edgar Link pending
laz-ex1019_1190.htm Edgar Link pending
laz-ex1020_763.htm Edgar Link pending
laz-ex1021_762.htm Edgar Link pending
laz-ex311_9.htm Edgar Link pending
laz-ex312_6.htm Edgar Link pending
laz-ex321_8.htm Edgar Link pending
laz-ex322_7.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending